Intranasal insulin (Johns Hopkins University)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameIntranasal insulin (Johns Hopkins University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsAIDS Dementia Complex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsAIDS Dementia Complex

Other Information

ATC CodeN/A
Related LinksN/A